Over more than two decades in Africa, UCSF researchers have approached their scientific work with a dual aim: treat disease while helping to sustainably build up the local health care system.
December 03, 2013
November 25, 2013
After heading the Obama administration’s global effort on AIDS, Eric Goosby is returning to his roots at UCSF to apply his experiences to improving public health programs.
November 06, 2013
David Baltimore, PhD, will present the 2013 Gladstone Distinguished Lecture on Wednesday, Nov. 20. The lecture, titled, “The Role of MicroRNAs in Immune Functions,” will begin at 4 p.m. in Gladstone’s Robert Mahley Auditorium.
October 01, 2013
UCSF researchers received six of 78 awards announced this week by the National Institutes of Health for innovative, high-risk, high-reward research.
September 30, 2013
Three Gladstone scientists have won research awards from divisions of the National Institutes of Health equaling an approximate total of $12.5 million over five years for their groundbreaking research to overcome HIV/AIDS.
July 11, 2013
With 10 days to go before AIDS Walk San Francisco, UCSF is working to get members of the University community to sign up for or contribute to the annual fundraiser to support programs and services to treat and prevent HIV/AIDS.
July 10, 2013
A new study by UCSF researchers points to changes in intestinal bacteria as a possible explanation for why successfully treated HIV patients nonetheless experience life-shortening chronic diseases.
June 25, 2013
Two veteran UCSF doctors who have been battling the AIDS epidemic for decades retraced past efforts and described their ongoing quest for a cure for HIV in the Academic Senate’s Third Annual Faculty Research Lecture.
May 13, 2013
UC San Francisco, a frequent high-performing team at AIDS Walk San Francisco, will again for the gold – the honor given to the top fundraising organizations participating in the annual event.
March 05, 2013
Community intervention with free mobile HIV testing and counseling, same-day results and post-test support led to a 14 percent reduction in new HIV infections in targeted communities in Sub-Saharan Africa, according to results of a large randomized, controlled trial.